105 related articles for article (PubMed ID: 32202907)
1. Monitoring of lung malignant epithelial cells by gene methylation analysis in the conditionally reprogrammed cell cultures.
Wu GD; Xiao YG; Fang FY; Yao D; Liu J; Cao YH; Mao Y; Yu B; Yao TR; Wu YM; Qian YH; Yu DH
Neoplasma; 2020 May; 67(3):692-699. PubMed ID: 32202907
[TBL] [Abstract][Full Text] [Related]
2. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
3. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
Chu X; Zhao W; Wang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
[TBL] [Abstract][Full Text] [Related]
4. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients.
Schotten LM; Darwiche K; Seweryn M; Yildiz V; Kneuertz PJ; Eberhardt WEE; Eisenmann S; Welter S; Sisson BE; Pietrzak M; Wiesweg M; Ploenes T; Hager T; He K; Freitag L; Aigner C; Taube C; Oezkan F
Eur J Cancer; 2021 Apr; 147():142-150. PubMed ID: 33662689
[TBL] [Abstract][Full Text] [Related]
6. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
7. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
8. The performance of the
Xu Z; Wang Y; Wang L; Xiong J; Wang H; Cui F; Peng H
Biomark Med; 2020 Apr; 14(5):341-351. PubMed ID: 32250153
[No Abstract] [Full Text] [Related]
9. Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
Sette G; Salvati V; Giordani I; Pilozzi E; Quacquarini D; Duranti E; De Nicola F; Pallocca M; Fanciulli M; Falchi M; Pallini R; De Maria R; Eramo A
Int J Cancer; 2018 Jul; 143(1):88-99. PubMed ID: 29341112
[TBL] [Abstract][Full Text] [Related]
10. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
Ji XY; Li H; Chen HH; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
13. Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.
Gao B; Huang C; Kernstine K; Pelekanou V; Kluger Y; Jiang T; Peters-Hall JR; Coquelin M; Girard L; Zhang W; Huffman K; Oliver D; Kinose F; Haura E; Teer JK; Rix U; Le AT; Aisner DL; Varella-Garcia M; Doebele RC; Covington KR; Hampton OA; Doddapaneni HV; Jayaseelan JC; Hu J; Wheeler DA; Shay JW; Rimm DL; Gazdar A; Minna JD
Oncotarget; 2017 Feb; 8(7):11114-11126. PubMed ID: 28052041
[TBL] [Abstract][Full Text] [Related]
14. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
Liu Q; Wang S; Pei G; Yang Y; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
[TBL] [Abstract][Full Text] [Related]
16. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
17. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
[TBL] [Abstract][Full Text] [Related]
18. SHOX2 methylation in Vietnamese patients with lung cancer.
Vo TTL; Nguyen TN; Nguyen TT; Pham ATD; Vuong DL; Ta VT; Ho VS
Mol Biol Rep; 2022 May; 49(5):3413-3421. PubMed ID: 35088378
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Zhou X; Lu X; Wu H; Liu J; Huang H
Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
[TBL] [Abstract][Full Text] [Related]
20. Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging.
Darwiche K; Zarogoulidis P; Baehner K; Welter S; Tetzner R; Wohlschlaeger J; Theegarten D; Nakajima T; Freitag L
Ann Oncol; 2013 Nov; 24(11):2866-70. PubMed ID: 24026539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
